Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317502053> ?p ?o ?g. }
- W4317502053 abstract "In the PREVENT-19 phase 3 trial of the NVX-CoV2373 vaccine (NCT04611802), anti-spike binding IgG concentration (spike IgG), anti-RBD binding IgG concentration (RBD IgG), and pseudovirus 50% neutralizing antibody titer (nAb ID50) measured two weeks post-dose two are assessed as correlates of risk and as correlates of protection against COVID-19. Analyses are conducted in the U.S. cohort of baseline SARS-CoV-2 negative per-protocol participants using a case-cohort design that measures the markers from all 12 vaccine recipient breakthrough COVID-19 cases starting 7 days post antibody measurement and from 639 vaccine recipient non-cases. All markers are inversely associated with COVID-19 risk and directly associated with vaccine efficacy. In vaccine recipients with nAb ID50 titers of 50, 100, and 7230 international units (IU50)/ml, vaccine efficacy estimates are 75.7% (49.8%, 93.2%), 81.7% (66.3%, 93.2%), and 96.8% (88.3%, 99.3%). The results support potential cross-vaccine platform applications of these markers for guiding decisions about vaccine approval and use." @default.
- W4317502053 created "2023-01-20" @default.
- W4317502053 creator A5002540504 @default.
- W4317502053 creator A5004348100 @default.
- W4317502053 creator A5007289352 @default.
- W4317502053 creator A5009785426 @default.
- W4317502053 creator A5013178279 @default.
- W4317502053 creator A5019357485 @default.
- W4317502053 creator A5020230187 @default.
- W4317502053 creator A5021959335 @default.
- W4317502053 creator A5023252020 @default.
- W4317502053 creator A5025149327 @default.
- W4317502053 creator A5027295416 @default.
- W4317502053 creator A5028172291 @default.
- W4317502053 creator A5029754572 @default.
- W4317502053 creator A5036401180 @default.
- W4317502053 creator A5039529693 @default.
- W4317502053 creator A5042931433 @default.
- W4317502053 creator A5049168902 @default.
- W4317502053 creator A5051550648 @default.
- W4317502053 creator A5051696264 @default.
- W4317502053 creator A5052150473 @default.
- W4317502053 creator A5053577218 @default.
- W4317502053 creator A5055605804 @default.
- W4317502053 creator A5056611428 @default.
- W4317502053 creator A5059344251 @default.
- W4317502053 creator A5064259175 @default.
- W4317502053 creator A5065895494 @default.
- W4317502053 creator A5066439531 @default.
- W4317502053 creator A5069748200 @default.
- W4317502053 creator A5072764896 @default.
- W4317502053 creator A5073659364 @default.
- W4317502053 creator A5074787043 @default.
- W4317502053 creator A5079872560 @default.
- W4317502053 creator A5080344225 @default.
- W4317502053 creator A5083172043 @default.
- W4317502053 creator A5085731242 @default.
- W4317502053 creator A5085762412 @default.
- W4317502053 creator A5091382675 @default.
- W4317502053 date "2023-01-19" @default.
- W4317502053 modified "2023-10-17" @default.
- W4317502053 title "Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial" @default.
- W4317502053 cites W2053301665 @default.
- W4317502053 cites W2102296058 @default.
- W4317502053 cites W2160358721 @default.
- W4317502053 cites W2887138610 @default.
- W4317502053 cites W2889551869 @default.
- W4317502053 cites W2952045272 @default.
- W4317502053 cites W3080581616 @default.
- W4317502053 cites W3081892744 @default.
- W4317502053 cites W3106869271 @default.
- W4317502053 cites W3108193091 @default.
- W4317502053 cites W3117382778 @default.
- W4317502053 cites W3131762051 @default.
- W4317502053 cites W3137970801 @default.
- W4317502053 cites W3153508314 @default.
- W4317502053 cites W3164547793 @default.
- W4317502053 cites W3172273960 @default.
- W4317502053 cites W3174017401 @default.
- W4317502053 cites W3187723563 @default.
- W4317502053 cites W3189985782 @default.
- W4317502053 cites W3198499417 @default.
- W4317502053 cites W3201221804 @default.
- W4317502053 cites W3203630421 @default.
- W4317502053 cites W3211857494 @default.
- W4317502053 cites W3217661335 @default.
- W4317502053 cites W4205483821 @default.
- W4317502053 cites W4211200665 @default.
- W4317502053 cites W4220734224 @default.
- W4317502053 cites W4221017555 @default.
- W4317502053 cites W4225470021 @default.
- W4317502053 cites W4226023532 @default.
- W4317502053 cites W4229336054 @default.
- W4317502053 cites W4233056867 @default.
- W4317502053 cites W4254617165 @default.
- W4317502053 cites W4281687206 @default.
- W4317502053 cites W4281843570 @default.
- W4317502053 cites W4281996593 @default.
- W4317502053 cites W4285804275 @default.
- W4317502053 cites W4308774038 @default.
- W4317502053 cites W81897278 @default.
- W4317502053 doi "https://doi.org/10.1038/s41467-022-35768-3" @default.
- W4317502053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36658109" @default.
- W4317502053 hasPublicationYear "2023" @default.
- W4317502053 type Work @default.
- W4317502053 citedByCount "18" @default.
- W4317502053 countsByYear W43175020532023 @default.
- W4317502053 crossrefType "journal-article" @default.
- W4317502053 hasAuthorship W4317502053A5002540504 @default.
- W4317502053 hasAuthorship W4317502053A5004348100 @default.
- W4317502053 hasAuthorship W4317502053A5007289352 @default.
- W4317502053 hasAuthorship W4317502053A5009785426 @default.
- W4317502053 hasAuthorship W4317502053A5013178279 @default.
- W4317502053 hasAuthorship W4317502053A5019357485 @default.
- W4317502053 hasAuthorship W4317502053A5020230187 @default.
- W4317502053 hasAuthorship W4317502053A5021959335 @default.
- W4317502053 hasAuthorship W4317502053A5023252020 @default.
- W4317502053 hasAuthorship W4317502053A5025149327 @default.
- W4317502053 hasAuthorship W4317502053A5027295416 @default.
- W4317502053 hasAuthorship W4317502053A5028172291 @default.